![Peter A. Zorn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter A. Zorn
President bij
Genevant Sciences, Inc.
Profiel
Peter A. Zorn currently works at Genevant Sciences Corp., as Chief Operating Officer from 2019, Genevant Sciences, Inc., as President & Chief Legal Officer from 2020, and Womble Bond Dickinson (US) LLP.
Mr. Zorn also formerly worked at Targacept, Inc., as Secretary, SVP-Legal Affairs & General Counsel from 2010 to 2013, Roche Innovation Center Copenhagen A, as General Counsel & Vice President-Communications, and Albireo Pharma, Inc., as Secretary & General Counsel from 2015 to 2018.
Mr. Zorn received his undergraduate degree from Harvard University and graduate degree from The University of North Carolina at Charlotte.
Actieve functies van Peter A. Zorn
| Bedrijven | Functie | Begin |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Operationeel Directeur | 07-01-2019 |
Genevant Sciences, Inc.
 Genevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company | President | 01-07-2020 |
Eerdere bekende functies van Peter A. Zorn
| Bedrijven | Functie | Einde |
|---|---|---|
| ALBIREO PHARMA, INC. | Algemeen Adviseur | 01-04-2018 |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Algemeen Adviseur | 30-09-2013 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Public Communications Contact | - |
Opleiding van Peter A. Zorn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
32
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Genevant Sciences, Inc.
Genevant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company | Health Technology |
